Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

2009·6.991 Zitationen·New England Journal of MedicineOpen Access

Volltext beim Verlag öffnen

6.991

Zitationen

Autoren

2009

Jahr

Abstract

In patients who have an acute coronary syndrome with or without ST-segment elevation, treatment with ticagrelor as compared with clopidogrel significantly reduced the rate of death from vascular causes, myocardial infarction, or stroke without an increase in the rate of overall major bleeding but with an increase in the rate of non-procedure-related bleeding. (ClinicalTrials.gov number, NCT00391872.)

Ähnliche Arbeiten

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

2014 · 11.546 Zit.

Apixaban versus Warfarin in Patients with Atrial Fibrillation

2011 · 8.808 Zit.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

2012 · 8.503 Zit.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

2002 · 6.927 Zit.

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

2007 · 6.689 Zit.

Autoren

Institutionen

Themen

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes

Volltext beim Verlag öffnen